Skip to main content
. 2022 May 25;13:845038. doi: 10.3389/fmicb.2022.845038

Table 3.

COG functional analysis between patients with MI and HC.

Functions Healthy group MI group Regulation in MI group
RNA processing and modification 0.012 0.014 Up-regulated
Chromatin structure and dynamics 0.035 0.037 Up-regulated
Energy production and conversion 6.050 6.051 Up-regulated
Cell cycle control, cell division, chromosome partitioning 1.124 1.104 Down-regulated
Amino acid transport and metabolism 9.523 9.563 Up-regulated
Nucleotide transport and metabolism 3.257 3.169 Down-regulated
Carbohydrate transport and metabolism 6.758 6.840 Up-regulated
Coenzyme transport and metabolism 4.744 4.676 Down-regulated
Lipid transport and metabolism 3.364 3.340 Down-regulated
Translation, ribosomal structure, and biogenesis 7.785 7.559 Down-regulated
Transcription 6.922 6.895 Down-regulated
Replication, recombination, and repair 5.219 5.113 Down-regulated
Cell wall/membrane/envelope biogenesis 6.347 6.249 Down-regulated
Cell motility 1.418 1.453 Up-regulated
Posttranslational modification, protein turnover, chaperones 3.632 3.668 Up-regulated
Inorganic ion transport and metabolism 5.047 5.127 Up-regulated
Secondary metabolites biosynthesis, transport, and catabolism 1.625 1.659 Up-regulated
General function prediction only 11.625 11.70 Up-regulated
Function unknown 7.257 7.432 Up-regulated
Signal transduction mechanisms 4.019 4.095 Up-regulated
Intracellular trafficking, secretion, and vesicular transport 2.222 2.259 Up-regulated
Defense mechanisms 2.001 1.974 Down-regulated
Extracellular structures 0.427 0.268 Down-regulated
Cytoskeleton 0.426 0.464 Up-regulated

The average relative abundance of COG pathway and significant difference were verified with a Wilcoxon signed-rank test in GraphPad Prism and p <0.05 suggests significant variance between both the groups.